StockData
Immunome Inc. logo

Immunome Inc. (IMNM) stock

IMNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$17.18−0.43 (-2.44%)

Close on Nov 17, 2026Market cap $1.95BP/E –Yield –

Immunome market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Immunome's market cap was $2.16B on Nov 11, 2026, against $1.69B a year earlier. Over the last 5 years it ranged from $26.80M to $3.10B, with a median of $641.68M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.16B+9.6%
2025Dec 31, 2025$1.97B+207.0%
2024Dec 31, 2024$641.68M+391.5%
2023Dec 29, 2023$130.57M+387.2%
2022Dec 30, 2022$26.80M-82.9%
2021Dec 31, 2021$156.73M+1339.7%
2020Dec 31, 2020$10.89M–

More Immunome figures

See a number that looks wrong?